GlassScriptPhysician profile
Maitri Mehta
NPI 1326500331
$2,106.21
in general payments reported to CMS, 2019-2025
13 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $20.74 · 2024: $1,050 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,106.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $404.71 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $338.13 | 2023-2025 | Idosetr, Idose, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is |
| Bausch & Lomb Americas INC. | $332.92 | 2024-2025 | Xiidra, Miebo, Vyzulta |
| Alcon Vision LLC | $318.86 | 2024-2025 | Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity, Clareon |
| Harrow Eye, LLC | $203.34 | 2024-2025 | Vevye |
| Abbvie INC. | $176.90 | 2024-2025 | |
| New World Medical,INC. | $123.80 | 2025 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Dompe US, INC. | $53.74 | 2024-2025 | Oxervate |
| Biotissue Holdings INC. | $40.99 | 2024-2025 | |
| Thea Pharma INC. | $40.62 | 2024-2025 | Iyuzeh |
| Astellas Pharma US INC | $31.56 | 2024 | Izervay |
| Rxsight INC | $22.13 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Rayner Intraocular Lenses Limited | $18.51 | 2024 | Omidria, Rayone Emv, Rayone Aspheric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maitri Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.